Breakthrough in Obesity Solutions: Fuzzle’s Non-Invasive Oral Device Begins FDA Review ProcessDover, DE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- In a major step forward for obesity solutions, Fuzzle, a pioneering health technology company, announced today that its innovative oral device has officially entered the U.S. Food and Drug Administration (FDA) review process.
